Skip to content

Comparison of programmed parameters of three chamber pacemaker based on echocardiographic finding versus factory suggested parameters

Comparison effect of three chamber pacemaker in patients with systolic dysfunction, on sign and symptom when its programmed based on echo cardiography versus factory suggested

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201102232474N3
Enrollment
40
Registered
2011-09-28
Start date
2010-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Left Ventricular Systolic Dysfunction. Dilated Cardiomyopathy

Interventions

Intervention 1: Intervention:After implantation of three chamber pace maker " device is programmed on echo cardiography guided and patient should be followed after 2 month. Intervention 2: Control:in
Treatment - Devices
Treatment - Drugs
Intervention:After implantation of three chamber pace maker " device is programmed on echo cardiography guided and patient should be followed after 2 month.
Control:in this group after implantation of pace maker , device is programmed on factory consults and patient followed after 2 month.

Sponsors

Vice chancellor for research Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: inclusion criteria:patient with systolic left ventricular dysfunction; Ejection fraction120ms. exclusion criteria:severe structural valvular disease;Intra cardiac shunt

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Function Class. Timepoint: Befor intervention and two month after intervention. Method of measurement: 6min walk.

Secondary

MeasureTime frame
Left Ventricular Function. Timepoint: Befor intervention and two month after intervention. Method of measurement: Echocardiography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Fariborz Akbarzadeh

Tabriz University of Medical Sciences

F_AKBARZADEH@Yahoo.Com+98 914 114 2328

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026